SAN FRANCISCO (PRWEB)
December 11, 2019

Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today the appointment of two industry leaders to its scientific advisory board. The new members are Thomas Large, PhD, currently CEO and Co-founder of Blue Oak Pharmaceuticals and formerly of Sunovion and Eli Lilly, and James Summers, PhD, formerly Vice President of Neuroscience Research at AbbVie.

“We are excited to welcome these accomplished industry veterans with expertise in discovering and developing therapies to treat neurological diseases to Verge’s advisory board” said Alice Zhang, Co-founder and Chief Executive Officer of Verge Genomics. “Drs Large and Summers’ collective experience will be invaluable as we advance our highly promising drug candidates for ALS and Parkinson’s disease toward the clinic.”

Thomas Large, PhD

Dr. Large brings more than 20 years of drug discovery, research and translational medicine experience to Verge’s scientific board. Currently, he is CEO and Co-Founder of Blue Oak Pharmaceuticals, a start-up integrating systems neurobiology, chemistry and informatics to discover drugs with new mechanisms of action for brain disorders.

Previously, Dr. Large was Senior Vice President, Preclinical Research and Translational Medicine at Sunovion Pharmaceuticals Inc. Under his leadership, the group pioneered a target-agnostic approach for CNS drugs, delivering multiple programs now in clinical development including SEP-363856 for schizophrenia, which was recently designated an FDA Breakthrough Therapy. Prior to Sunovion, Dr. Large was a scientific and group leader at Eli Lilly in neuroscience research, where he led projects that resulted in therapeutic candidates for anxiety, psychosis and pain. During his tenure at Eli Lilly, Dr. Large also managed a group developing innovative approaches for drug targets in the CNS, endocrine and oncology therapeutic areas.

Dr. Large holds a PhD in neurobiology and physiology from Northwestern University and completed a Howard Hughes postdoctoral fellowship at the University of California, San Francisco. Dr. Large previously served as a faculty member of the Department of Neurosciences at Case Western Reserve University Medical School.

James Summers, PhD

Dr. Summers brings over 30 years of drug discovery and pharmaceutical research management experience to Verge’s scientific advisory board. Previously, he was Vice President of Neuroscience Research at AbbVie, where he led efforts focused on the discovery of new treatments for Alzheimer’s and Parkinson’s diseases, pain, and psychiatric disorders. Under his leadership, his teams advanced more than twenty compounds into development. He established new research sites in Cambridge, MA and Shanghai, China, was an architect of several strategies that defined the future direction of Abbvie’s global research organizations, and championed multiple successful out-licensing deals, biotech collaborations and venture investments. He currently serves on the board of directors and as an advisor to several biotechnology companies.

Dr. Summers earned his Bachelor of Science degree, summa cum laude, in chemistry from Denison University and his doctorate in organic chemistry from Harvard University.

About Verge Genomics

Verge is focused on developing therapeutics for neurological diseases using human genomics to accelerate drug discovery. Verge has created a proprietary all-in-human platform, generating one of the field’s largest and most comprehensive databases of ALS and Parkinson’s Disease patient genomic data. The Company is led by experienced computational biologists and drug developers who are successfully advancing therapeutic programs in ALS and Parkinson’s disease toward the clinic. For additional information, please visit http://www.vergegenomics.com.

Contacts

for Verge Genomics

Shannon Stone, PhD

415-854-5500

shannon@vergegenomics.com

Share article on social media or email:

GRANT PASS, Ore. (PRWEB)
December 12, 2019

Air Date: 9 December 2019

Guest: Anouche Moshari Roberts, M.D., The Liquid Facelift and Laser Center, Northern Virginia

https://www.voiceamerica.com/episode/119096/do-you-suffer-from-dry-eye-and-dry-skin

“We humans,” says Sharon Kleyne, founder and research director of Bio Logic Aqua® Research Water Life Science® in Grants Pass, Oregon and the host of the internationally syndicated radio program, The Sharon Kleyne Hour Water Life Science®/Nature’s Pharma®, The Power of Water® & Your Health sponsored by Nature’s Tears® EyeMist® on VoiceAmerica and produced by Rose Hong, founder and director of Global Dragon TV in Washington, D.C., “have a tendency to take for granted and ignore what is all around us—water. Yet, what is happening to the human body is also happening to the planet earth and the solar system. Have you noticed,” continues Kleyne, “that everything seems out of control? I blame that on the lack of education. So, I decided to start the educational Health Olympics.”

The moment one is born, Kleyne teaches, one begins to evaporate water. “From birth,” Kleyne says, “we should be educating ourselves about our health, about living in rhythm with the planet and the solar system.” Kleyne accuses politicians of not making water a priority, “Dry eye, for example, is vision impairment from birth. The surface of the eye is 99 percent water. It is common sense!” Kleyne insists. “You must drink pure water—one full glass at a time—throughout the day and night. If you don’t drink enough water, dry eye will get worse, and that can lead to additional impairment and potential blindness.” That is why Kleyne invented Nature’s Tears® EyeMist®, pure water technology to supplement the always-evaporating tear film. “We need to improve the water education of our children,” Kleyne says.

Anouche Moshari Roberts, trained as an ophthalmologist, born in Iran, raised in Germany and guiding The Liquid Facelift and Laser Center in Northern Virginia, agrees. “Dry eye is common,” Roberts commiserates. “The good news is you can treat it easily; the bad news is that it can cause vision problems.” Roberts shares that dry eye symptoms include a scratchy feeling, like sand in the eye, stinging, redness and blurred vision. “Also,” Roberts reveals, “children are staring too much at screens. This dries out the oil ducts around the tear film. Children need to be taught to remember to blink regularly. They’re also not drinking enough water during the day.”

Roberts’s The Liquid Facelift and Laser Center offers revolutionary non-invasive i-Lipo body contouring laser treatments, as well as treatments with the Icon Laser by Palomar Medical. Yet, Roberts agrees with Kleyne that it all begins with getting a handle on body water evaporation if one hopes to maintain healthy eyes and skin.

Drinking water, supplementing the eyes with Nature’s Tears® EyeMist®, educating ourselves from birth about water vapor evaporation and supplemental water technology, and embracing the Health Olympics will finally get dry eye, dry skin and blindness under control,” says Kleyne.

If you would like to listen to the program featuring Anouche Moshari Roberts, M.D. of The Liquid Facelift and Laser Center in Northern Virginia and water evaporation and education Health Olympics researcher Sharon Kleyne during which they discuss dry eye, blindness, body water evaporation, education and the Health Olympics, dry skin, symptoms and causes of dry skin dry eye and relief of dry eye with Nature’s Tears® EyeMist®, you may do so by following this link: https://www.voiceamerica.com/episode/119096/do-you-suffer-from-dry-eye-and-dry-skin

If you wish to see a brief educational film that demonstrates the application of the new Dry Eye Solution® technology Nature’s Tears® EyeMist®, go here: https://www.youtube.com/watch?v=l0gOr8TB45U

Share article on social media or email: